AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,495,000 | +25.8% | 66,540 | +1.0% | 2.25% | +14.8% |
| Q1 2018 | $3,573,000 | -15.0% | 65,865 | -6.4% | 1.96% | -10.6% |
| Q4 2017 | $4,204,000 | +16.6% | 70,365 | -5.1% | 2.19% | +9.1% |
| Q3 2017 | $3,604,000 | -13.8% | 74,155 | -6.8% | 2.00% | -15.1% |
| Q2 2017 | $4,179,000 | +21.8% | 79,525 | +5.2% | 2.36% | +15.0% |
| Q1 2017 | $3,430,000 | +12.0% | 75,625 | -6.6% | 2.05% | +10.3% |
| Q4 2016 | $3,063,000 | -5.0% | 80,935 | -5.3% | 1.86% | -8.8% |
| Q3 2016 | $3,225,000 | +99.7% | 85,445 | -6.9% | 2.04% | +85.8% |
| Q2 2016 | $1,615,000 | +37.8% | 91,770 | -4.8% | 1.10% | +33.1% |
| Q1 2016 | $1,172,000 | -49.4% | 96,395 | +1.4% | 0.83% | -50.9% |
| Q4 2015 | $2,316,000 | +39.9% | 95,100 | +1.9% | 1.68% | +32.8% |
| Q3 2015 | $1,655,000 | +5.8% | 93,320 | +5.3% | 1.27% | +12.7% |
| Q2 2015 | $1,565,000 | +617.9% | 88,660 | +1174.8% | 1.12% | +597.5% |
| Q1 2015 | $218,000 | – | 6,955 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,672,714 | $63,128,000 | 30.14% |
| Foresite Capital Management III, LLC | 1,697,884 | $64,078,000 | 29.95% |
| Asymmetry Capital Management, L.P. | 150,651 | $5,686,000 | 9.89% |
| ACUTA CAPITAL PARTNERS, LLC | 280,000 | $10,567,000 | 3.97% |
| Avoro Capital Advisors LLC | 500,000 | $18,870,000 | 3.31% |
| Convector Capital Management, LP | 38,444 | $1,451,000 | 2.66% |
| DAFNA Capital Management LLC | 91,869 | $3,467,000 | 2.42% |
| Partner Investment Management, L.P. | 42,438 | $1,602,000 | 2.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,338,829 | $50,527,000 | 2.35% |
| Iguana Healthcare Management, LLC | 330,000 | $12,454,000 | 2.22% |